This report highlights azathioprine-induced severe myelosuppression in the patient with NUDT15 minor variant. This case report is particularly instructive because several typical symptoms are the clues to this critical adverse drug reaction.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385330 | PMC |
| http://dx.doi.org/10.1002/ccr3.4696 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Filgrastim Use in the Treatment of Azathioprine-Induced Myelosuppression Toxicity After Prescription Error in the Feline.
J Am Anim Hosp Assoc
May 2024
From Foxboro Animal Hospital, Foxboro, MA.
Only one report on the successful use of filgrastim (granulocyte colony-stimulating factor) in cats for severe neutropenia following azathioprine toxicity exists. Here, we report on a case in which a cat was prescribed methimazole but the medication was filled incorrectly with azathioprine tablets and the prescription label indicated a methimazole dosing regimen that was administered for three days before recognition of the error. On presentation, the cat's physical examinations were consistent with previous examinations before ingestion of azathioprine.
View Article and Find Full Text PDFSevere azathioprine-induced liver injury 22 months after initiation of treatment.
Drug Ther Bull
March 2024
Liver and Gastroenterology Unit, ASST Santi Paolo e Carlo, Milan, Italy.
Crusted Scabies Presenting as Erythroderma in a Patient With Iatrogenic Immunosuppression for Treatment of Granulomatosis With Polyangiitis.
Cutis
May 2023
Yale School of Medicine, New Haven, Connecticut. Drs. Leventhal and Vesely are from the Department of Dermatology.
The diagnosis of scabies can be difficult when the infection presents as erythroderma. Crusted scabies is a severe form of scabies caused by cutaneous ectoparasitic infection by the mite Sarcoptes scabiei var hominis. Crusted scabies most commonly occurs in patients with underlying immunosuppression from acquired infection or subsequent to solid organ or bone marrow transplantation.
View Article and Find Full Text PDFCase report: polymorphism and severe azathioprine-induced myelosuppression in a young Chinese female with systematic lupus erythematosus: a case analysis and literature review.
Front Pharmacol
May 2023
Department of Pharmacy, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
Article Synopsis
- Azathioprine (AZA) is used to suppress the immune system in autoimmune diseases but can cause serious side effects like myelosuppression, especially due to genetic differences in metabolism.
- The study highlights a case of a young Chinese woman with specific genetic variations who experienced severe side effects after high doses of AZA for lupus, without proper monitoring of blood cell counts.
- A systematic review of similar cases reveals patterns in blood cell changes associated with genetic variants, aiming to improve clinical management and treatment outcomes for patients on AZA.
Azathioprine-induced vanishing bile duct syndrome: The value of early thiopurine metabolism assessment.
Br J Clin Pharmacol
August 2023
Unité de Pharmacogénétique, Service de Biochimie, Hôpital européen Georges Pompidou, AP-HP.Centre, Université Paris Cité, Paris, France.
Article Synopsis
- A 34-year-old woman on azathioprine for lupus developed serious liver problems, leading to a diagnosis of ductopenia after blood tests showed abnormal metabolite levels.
- The case highlights the rarity of ductopenia as a side effect of azathioprine and suggests that monitoring blood levels of thiopurine metabolites could help identify patients at risk of liver damage.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!